Carolyn Lam Singapore-born cardiologist
Lam, Carolyn S.P.
Lam, Carolyn Su Ping, 1974-
VIAF ID: 311464118 (Personal)
Permalink: http://viaf.org/viaf/311464118
Preferred Forms
- 100 0 _ ‡a Carolyn Lam ‡c Singapore-born cardiologist
- 100 1 _ ‡a Lam, Carolyn S. P.
- 100 1 _ ‡a Lam, Carolyn S. P.
- 100 1 _ ‡a Lam, Carolyn S.P.
-
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
Novel insights into heart failure with preserved ejection fraction | |
Obesity-Related Changes in Cardiac Structure and Function Among Asian Men and Women | |
Paradoxical Low-Gradient Aortic Stenosis: The HFpEF of Aortic Stenosis | |
Plasma extracellular vesicle protein content for diagnosis and prognosis of global cardiovascular disease. | |
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration | |
Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study | |
Potassium abnormalities in patients with heart failure from 11 Asian regions: insights from the ASIAN-HF registry | |
The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors | |
Prevalence and Clinical Significance of Diabetes in Asian Versus White Patients With Heart Failure | |
Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure | |
Prognosis of Adults With Borderline Left Ventricular Ejection Fraction | |
Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophic cardiomyopathy | |
Pulmonary pressures and death in heart failure: a community study | |
Qishen Yiqi dripping pills for chronic ischaemic heart failure: results of the CACT-IHF randomized clinical trial | |
Quality of Care of the Initial Patient Cohort of the Diabetes Collaborative Registry®. | |
Race-Related Differences in Left Ventricular Structural and Functional Remodeling in Response to Increased Afterload: The ARIC Study | |
Racial Differences in Electrocardiographic Characteristics and Prognostic Significance in Whites Versus Asians | |
Random Plasma Glucose Levels and Cardiovascular Risk | |
Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES). | |
Rationale and Design of the VITALITY-HFpEF Trial | |
The Relationship among Carotid Artery Remodeling, Cardiac Geometry, and Serum N-Terminal Pro-B-Type Natriuretic Peptide Level in Asymptomatic Asians: Sex-Differences and Longitudinal GEE Study | |
The relationship between renal impairment and left ventricular structure, function, and ventricular-arterial interaction in hypertension | |
Reply in response to 'Defining a "frequent admitter" phenotype among patients with repeat heart failure admissions' | |
Revisiting methods for assessing and comparing left ventricular diastolic stiffness: impact of relaxation, external forces, hypertrophy, and comparators | |
Risk Factors for Heart Failure: 20-Year Population-Based Trends by Sex, Socioeconomic Status, and Ethnicity | |
Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study | |
Risk stratification of Asian patients with heart failure and reduced ejection fraction: the effectiveness of the Echo Heart Failure Score | |
Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease | |
The role of N-terminal pro-B-type natriuretic peptide in prognostic evaluation of heart failure | |
Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice | |
Sex and cardiovascular risk: are women advantaged or men disadvantaged? | |
Sex differences in heart failure | |
Sex differences in mineralocorticoid receptor antagonist trials: a pooled analysis of three large clinical trials | |
Sex Differences in Primary and Secondary Prevention of Cardiovascular Disease in China | |
SGLT-2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects | |
The Singapore Heart Failure Outcomes and Phenotypes | |
Single-dose intravenous iron in Southeast Asian heart failure patients: A pilot randomized placebo-controlled study (PRACTICE-ASIA-HF) | |
Size, shape, and stamina: the impact of left ventricular geometry on exercise capacity | |
The socioeconomics of hypertension: how $50 000 may buy a drop in blood pressure | |
Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis | |
Teaching cardiac auscultation without patient contact | |
Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarction | |
Understanding Contemporary Use of Thiazolidinediones | |
The Upcoming Epidemic of Heart Failure in South Asia | |
Variable phenotype in murine transverse aortic constriction | |
Vascular Health Indices and Cognitive Domain Function: Singapore Longitudinal Ageing Studies | |
Victims of Success in Failure | |
What is normal in HFNEF?: The case for HFpEF | |
Women's Participation in Cardiovascular Clinical Trials From 2010 to 2017 | |
World Heart Federation Roadmap for Heart Failure |